Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. latvia
  4. preclinical modeling
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Latvia
Business Types

  • Manufacturer
  • Technology
  • Service provider
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Agriculture
Employees

  • 101-1000
  • Over 1000

Preclinical Modeling Suppliers Serving Latvia

31 companies found
Serving LatviaNear Latvia

Emulate

Emulate

based inBoston, MASSACHUSETTS (USA)
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro ...
Emulate - Colon Intestine-Chip

Emulate - Colon Intestine-Chip

Investigate mechanisms of colon inflammation and barrier disruption and evaluate the efficacy of anti-inflammatory drug candidates in an organoid-derived ...
CONTACT SUPPLIER

Mersana Therapeutics

Mersana Therapeutics

based inCambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
DolaLock Technology

DolaLock Technology

Once ADCs release their cytotoxic payload into targeted cells, the drug is often able to cross cell membranes, entering and potentially killing neighboring cells whether those cells are cancerous or not. This effect is called bystander-killing, ...
CONTACT SUPPLIER

Healx Ltd.

Healx Ltd.

based inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
Healx - Rare Treatment Accelerator

Healx - Rare Treatment Accelerator

Our Rare Treatment Accelerator helps academic, patient, and industry groups advance their rare disease drug redevelopment projects. By combining our team, expertise and financial resources with your research and insights, we can get treatments to ...
CONTACT SUPPLIER

DSM

DSM

based inHeerlen, NETHERLANDS
DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our purpose is to create brighter lives for all. We achieve it by using all the scientific and innovation power at our disposal to tackle some ...
Drug Delivery System

Drug Delivery System

Discover our implantable drug delivery systems made of bioresorbable polymers that release precise quantities of therapeutic agents gradually over time. DSM is a global leader in biomedical materials science – experience that we are now using ...
CONTACT SUPPLIER

Sumitomo Pharma Oncology, Inc.

Sumitomo Pharma Oncology, Inc.

based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Sumitomo - Model DSP-0509 - TLR7 Agonist

Sumitomo - Model DSP-0509 - TLR7 Agonist

DSP-0509 is an investigational Toll-like receptor (TLR) 7 agonist, which is hypothesized to induce cytokine production, activate cytotoxic T lymphocytes, and sustain immune-mediated antitumor ...
CONTACT SUPPLIER

MorphoSys AG

MorphoSys AG

based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
CONTACT SUPPLIER

Ibio, Inc.

Ibio, Inc.

based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
IBIO - Model 101 - Immuno Oncology Therapeutics

IBIO - Model 101 - Immuno Oncology Therapeutics

Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid tumors, significant ...
CONTACT SUPPLIER

BioDiem Ltd.

BioDiem Ltd.

based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
Biodiem - Model BDM-I - Vaccine for Anti-infective Treatments

Biodiem - Model BDM-I - Vaccine for Anti-infective Treatments

BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious problem facing the global community is ...
CONTACT SUPPLIER

Virpax Pharmaceuticals

Virpax Pharmaceuticals

based inBerwyn, PENNSYLVANIA (USA)
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate. Our transforming ...
Virpax - Model Envelta - Endogenous Enkephalin Intranasal Spray

Virpax - Model Envelta - Endogenous Enkephalin Intranasal Spray

Endogenous peptides with analgesic potential include endorphins via binding to the mu receptor, dynorphins via the kappa receptor and enkephalins via the delta receptor. Kappa and delta opioid agonists have been shown to provide analgesic benefit ...
CONTACT SUPPLIER

Xtant Medical

Xtant Medical

based inBelgrade, MONTANA (USA)
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, ...
OsteoSelect - Osteoinductivity Graft

OsteoSelect - Osteoinductivity Graft

OsteoSelect was engineered for superior performance. The graft does not adhere to gloves yet maintains its placement in the surgical environment. Osteoinductivity of sterile final product is assessed in vivo. In this challenging model, every lot ...
CONTACT SUPPLIER

InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
InMed - Model INM-088 - Topical Eye Drop for the Treatment of Glaucoma

InMed - Model INM-088 - Topical Eye Drop for the Treatment of Glaucoma

INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide ...
CONTACT SUPPLIER

Aptorum Group Limited

Aptorum Group Limited

based inLondon, UNITED KINGDOM
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, ...
CONTACT SUPPLIER

Access Vascular, Inc.

Access Vascular, Inc.

based inBillerica, MASSACHUSETTS (USA)
Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX™ technology which is designed to prevent the most common and costly complications in vascular access. Keep treatment moving ...
CONTACT SUPPLIER

Curasight

Curasight

based inKøbenhavn N, DENMARK
Curasight is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor ...
CONTACT SUPPLIER

Kiadis Pharma NV

Kiadis Pharma NV

based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
Immuno-Oncology

Immuno-Oncology

Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening ...
CONTACT SUPPLIER

Moon (Guangzhou) Biotech Co.,Ltd

Moon (Guangzhou) Biotech Co.,Ltd

based inHuangpu District, CHINA
Moon (Guangzhou) Biotech Co., Ltd., with the title of National High-tech Enterprise, is an innovative biotechnology company focusing on the development and commercialization of microbial products and solutions. With a dedication to discover, ...
Moon Biotech - Microbiome Therapeutics

Moon Biotech - Microbiome Therapeutics

From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based drugs for improving human health and treating ...
CONTACT SUPPLIER

SCIREQ - an emka TECHNOLOGIES Company

SCIREQ - an emka TECHNOLOGIES Company

based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
Surgery Services

Surgery Services

Surgical skills are needed for all our implanted telemetry and for some in vitro isolated organs ...
CONTACT SUPPLIER

Pure Biologics SA

Pure Biologics SA

based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Pure Biologics - Model PB002 AptaPheresis - Therapeutic Medical Device

Pure Biologics - Model PB002 AptaPheresis - Therapeutic Medical Device

Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the pharmaceutical industry. However, ...
CONTACT SUPPLIER

Nisan Medical

Nisan Medical

based inAnkara, TURKEY
Nisan Medical is successfully operating in the industry for almost 30 years. They are especially creating turnkey hospital projects all around Turkey and operate the application. They work with key business partners for Central Sterilization Units ...
CONTACT SUPPLIER

Chimeric Therapeutics

Chimeric Therapeutics

based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Chimeric - Model CHM 1101 (CLTX CAR T) - T Cell Derived Autologous Therapies

Chimeric - Model CHM 1101 (CLTX CAR T) - T Cell Derived Autologous Therapies

CHM 1101 (CLTX CAR T) is an optimized first-in-class CAR T cell therapy that uniquely utilizes Chlorotoxin (CLTX), a 36-amino acid peptide derived from deathstalker scorpion venom as its tumour targeting ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT